$16.99 0.00 (0%)
8/11/2010 10:34 AM

Phase Forward, Inc. (NASDAQ:PFWD)

CAPS Rating: 2 out of 5

A provider of integrated enterprise-level software products, services and hosted solutions for use in its customers' global clinical trial and drug safety monitoring activities.

Featured Broker Partners


Advertisement